Promoting adherence to medicines: possible lessons for Canada?
Abstract Non-adherence to medication regimens is a major issue that can negatively impact patient health and wastes health care system resources. This commentary considers whether approaches to strategies undertaken in Israel to promote adherence could be viable in Canada. The structure of the Canad...
Saved in:
Main Author: | Nigel S. B. Rawson (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leading Causes of Mortality and Prescription Drug Coverage in Canada and New Zealand
by: Nigel S. B. Rawson, et al.
Published: (2020) -
National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability; Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
by: Nigel S. B. Rawson
Published: (2020) -
Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?
by: Rawson NS, et al.
Published: (2017) -
Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada
by: Rawson NSB, et al.
Published: (2024) -
THE PROBLEM OF ADHERENCE TO THE TREATMENT IN MODERN MEDICINE: POSSIBILITIES OF SOLUTION, IMPACT ON THE EFFECTIVENESS OF THERAPY AND DISEASE OUTCOMES
by: Yu. V. Lukina, et al.
Published: (2017)